Steven Robert Martin - Net Worth and Insider Trading

Steven Robert Martin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Steven Robert Martin owns 3 companies in total, including Armata Pharmaceuticals Inc (ARMP) , Seelos Therapeutics Inc (SEEL) , and Ensysce Biosciences Inc (ENSC) .

Click here to see the complete history of Steven Robert Martin’s form 4 insider trades.

Insider Ownership Summary of Steven Robert Martin

Ticker	Comapny	Transaction Date	Type of Owner
ARMP	Armata Pharmaceuticals Inc	2020-12-08	Chief Financial Officer
SEEL	Seelos Therapeutics Inc	2014-02-06	Senior VP & CFO
ENSC	Ensysce Biosciences Inc	2021-06-30	director

Steven Robert Martin Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Steven Robert Martin Ownership Network

Ownership Network List of Steven Robert Martin

No Data

Ownership Network Relation of Steven Robert Martin

Steven Robert Martin Owned Company Details

What does Armata Pharmaceuticals Inc do?

Who are the key executives at Armata Pharmaceuticals Inc?

Steven Robert Martin is the Chief Financial Officer of Armata Pharmaceuticals Inc. Other key executives at Armata Pharmaceuticals Inc include Corporate Controller and PFO Richard Rychlik , director & Chief Executive Officer Deborah Birx , and Chief Financial Officer Julianne Averill .

Armata Pharmaceuticals Inc (ARMP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Armata Pharmaceuticals Inc (ARMP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Armata Pharmaceuticals Inc (ARMP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Armata Pharmaceuticals Inc (ARMP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Armata Pharmaceuticals Inc Insider Transactions

No Available Data

What does Seelos Therapeutics Inc do?

Who are the key executives at Seelos Therapeutics Inc?

Steven Robert Martin is the Senior VP & CFO of Seelos Therapeutics Inc. Other key executives at Seelos Therapeutics Inc include director & See Remarks Raj Mehra , Chief Financial Officer Michael Joseph Golembiewski , and SVP & Chief Business Officer Neil Morton .

Seelos Therapeutics Inc (SEEL) Insider Trades Summary

Over the past 18 months, Steven Robert Martin made no insider transaction in Seelos Therapeutics Inc (SEEL). Other recent insider transactions involving Seelos Therapeutics Inc (SEEL) include a net purchase of 83,000 shares made by Michael Joseph Golembiewski , and a net purchase of 75,757 shares made by Raj Mehra .

In summary, during the past 3 months, insiders sold 0 shares of Seelos Therapeutics Inc (SEEL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Seelos Therapeutics Inc (SEEL) were sold and 19,845 shares were bought by its insiders, resulting in a net purchase of 19,845 shares.

Seelos Therapeutics Inc (SEEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Seelos Therapeutics Inc Insider Transactions

No Available Data

What does Ensysce Biosciences Inc do?

Who are the key executives at Ensysce Biosciences Inc?

Steven Robert Martin is the director of Ensysce Biosciences Inc. Other key executives at Ensysce Biosciences Inc include director & Chief Executive Officer Lynn Kirkpatrick , Chief Medical Officer Nilab Osman , and Chief Development Officer Linda Pestano .

Ensysce Biosciences Inc (ENSC) Insider Trades Summary

Over the past 18 months, Steven Robert Martin made no insider transaction in Ensysce Biosciences Inc (ENSC). Other recent insider transactions involving Ensysce Biosciences Inc (ENSC) include a net purchase of 447,430 shares made by Bob G Gower ,

In summary, during the past 3 months, insiders sold 0 shares of Ensysce Biosciences Inc (ENSC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ensysce Biosciences Inc (ENSC) were sold and 447,430 shares were bought by its insiders, resulting in a net purchase of 447,430 shares.

Ensysce Biosciences Inc (ENSC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ensysce Biosciences Inc Insider Transactions

No Available Data

Steven Robert Martin Mailing Address

Above is the net worth, insider trading, and ownership report for Steven Robert Martin. You might contact Steven Robert Martin via mailing address: 11011 North Torrey Pines Road, La Jolla Ca 92037.

Discussions on Steven Robert Martin

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.